Doylestown, PA, United States of America

Sean M Johnston

USPTO Granted Patents = 10 (Patent Applications = 17)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 45(Granted Patents)

Company Filing History:

7 out of 71

Paratek Pharmaceuticals, Inc.

patents

1 out of 1

Paratek Pharmaceuticals, Inc.-124418

Warner Chilcott Company, LLC

patents

5. 1 out of 2

Apnimed, Inc. (delaware)

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448347 - Polymorphic forms of (R)-oxybutynin hydrochloride (2025-10-21),

2. 12297161 - Process for making sarecycline hydrochloride (2025-05-13),

3. 10124014 - Minocycline compounds and methods of use thereof (2018-11-13),

4. 9724358 - Minocycline compounds and methods of use thereof (2017-08-08),

5. 9434680 - Methods for synthesizing and purifying aminoalkyl tetracycline compounds (2016-09-06),

6. 9314475 - Oral and injectable formulations of tetracycline compounds (2016-04-19),

7. 9265740 - Minocycline compounds and methods of use thereof (2016-02-23),

8. 9255068 - Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same (2016-02-09),

9. 9078811 - Methods of increasing oral bioavailability of tetracyclines (2015-07-14),

10. 8946196 - Methods for synthesizing and purifying aminoalkyl tetracycline compounds (2015-02-03),

Title: Inventor Spotlight: Sean M Johnston

Introduction

Sean M Johnston, an accomplished inventor based in Doylestown, PA, has made significant contributions to the field of pharmaceuticals with a particular focus on antibiotic treatments. With a total of eight patents to his name, Johnston's innovations have the potential to impact the medical community and improve patient care substantially.

Latest Patents

One of Sean M Johnston's notable recent patents involves the use of minocycline compounds for treating bacterial infections. He has developed methods and compositions that utilize a tetracycline compound to address various infections. For instance, one of his inventions provides a method for treating infections by administering an effective amount of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or its salts. This method targets infections, including Methicillin-Susceptible Staphylococcus Aureus (MSSA), Methicillin-Resistant Staphylococcus Aureus (MRSA), and Viridans, showcasing the broad applicability of his research.

Career Highlights

Throughout his career, Sean M Johnston has been associated with Paratek Pharmaceuticals, Inc., a leading company in the development of innovative antibiotics. His role in this organization has played a crucial part in advancing treatments for antibiotic-resistant infections, reflecting his commitment to addressing critical healthcare challenges.

Collaborations

During his time at Paratek Pharmaceuticals, Johnston has collaborated with professionals such as Robert D Arbeit and Thomas J Bigger. These partnerships have likely contributed to his success and the impact of his inventions, fostering an environment of shared knowledge and innovative thinking.

Conclusion

Sean M Johnston is a leading figure in the field of pharmaceuticals, whose innovative patented methods for treating bacterial infections represent a significant advancement in antibiotic therapy. With his ongoing contributions and collaborations, Johnston continues to make a meaningful impact on healthcare, inspiring future inventors and researchers in the medical field.

This text is generated by artificial intelligence and may not be accurate.